Over-expression of N-type calcium channels in cortical neurons from a mouse model of Amyotrophic Lateral Sclerosis

Experimental Neurology

Volumn 247, Issue , 2013, Pages 349-358

  Pieri, Massimo ^a,b   Caioli, Silvia ^a,b   Canu, Nadia ^a,c   Mercuri, Nicola B ^a,b   Guatteo, Ezia ^b   Zona, Cristina ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^c CNR   (Italy)

Author keywords

Calcium current; Cortex; Electrophysiology; Fura 2; G93A

Indexed keywords

CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CALCIUM ION; OMEGA CONOTOXIN GVIA; POTASSIUM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EMBRYO; EXCITOTOXICITY; GENE OVEREXPRESSION; IMMUNOCYTOCHEMISTRY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; MOTOR CORTEX; MOUSE; NERVE CELL CHARACTERISTICS AND FUNCTIONS; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEURONAL HYPEREXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WESTERN BLOTTING;

CALCIUM CURRENT; CORTEX; ELECTROPHYSIOLOGY; FURA-2; G93A;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, NEWBORN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYTOPHOTOMETRY; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; OMEGA-AGATOXIN IVA; OMEGA-CONOTOXIN GVIA; PATCH-CLAMP TECHNIQUES; SODIUM CHANNEL BLOCKERS; SUPEROXIDE DISMUTASE; TETRODOTOXIN;

EID: 84881368752     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2012.11.002     Document Type: Article

References (82)

1. Arundine M., Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003, 34:325-337.
2. Ashcroft F.M. From molecule to malady. Nature 2006, 440:440-447.
3. Augustine G.J., Santamaria F., Tanaka K. Local calcium signaling in neurons. Neuron 2003, 40:331-346.
4. Beers D.R., Ho B.K., Siklos L., Alexianu M.E., Mosier D.R., Mohamed A.H., Otsuka Y., Kozovska M.E., McAlhany R.E., Smith R.G., Appel S.H. Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J. Neurochem. 2001, 79:499-509.
5. 2+ levels in brainstem motorneurons from mouse. J. Physiol. 2004, 551:45-59.
6. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1:11-21.
7. Bertolino M., Llinas R.R. The central role of voltage-activated and receptor-operated calcium channels in neuronal cells. Annu. Rev. Pharmacol. Toxicol. 1992, 32:399-421.
8. 2+ microdomains on neurotransmitter release. Biophys. J. 1999, 76:735-750.
9. Billups B., Forsythe I.D. Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J. Neurosci. 2002, 22:5840-5847.
10. 2+ homeostasis. J. Neurochem. 1996, 66:403-411.
11. Caioli S., Curcio L., Pieri M., Antonini A., Marolda R., Severini C., Zona C. Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis. Neurobiol. Dis. 2011, 44:92-101.
12. Cali T., Ottolini D., Negro A., Brini M. Alpha-synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulum-mitochondria interactions. J. Biol. Chem. 2012, 287:17914-17929.
13. Caramia M.D., Palmieri M.G., Desiato M.T., Iani C., Scalise A., Telera S., Bernardi G. Pharmacologic reversal of cortical hyperexcitability in patients with ALS. Neurology 2000, 54:58-64.
14. Carunchio I., Pieri M., Ciotti M.T., Albo F., Zona C. Modulation of AMPA receptors in cultured cortical neurons induced by the antiepileptic drug levetiracetam. Epilepsia 2007, 48:654-662.
15. Carunchio I., Curcio L., Pieri M., Pica F., Caioli S., Viscomi M.T., Molinari M., Canu N., Bernardi G., Zona C. Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture. Exp. Neurol. 2010, 226:218-230.
16. 2+ currents show similar patterns of expression in stellate and pyramidal cells from rat entorhinal cortex layer II. Brain Res. 2006, 1090:76-88.
17. Catterall W.A., Few A.P. Calcium channel regulation and presynaptic plasticity. Neuron 2008, 59:882-901.
18. Cepeda C., Starling A.J., Wu N., Nguyen O.K., Uzgil B., Soda T., Andre V.M., Ariano M.A., Levine M.S. Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF. J. Neurosci. Res. 2004, 78:855-867.
19. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988, 1:623-634.
20. 2+ channels. Biochim. Biophys. Acta 2012, 1820:1243-1252.
21. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
22. Cleveland D.W., Rothstein J.D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2001, 2:806-819.
23. Enterzari-Taher M., Eisen A., Stewart H., Nakajima M. Abnormalities of cortical inhibitory neurons in amyotrophic lateral sclerosis. Muscle Nerve 1997, 20:65-71.
24. Feldmeyer D., Sakmann B. Synaptic efficacy and reliability of excitatory connections between the principal neurones of the input (layer 4) and output layer (layer 5) of the neocortex. J. Physiol. 2000, 525(Pt 1):31-39.
25. Feldmeyer D., Egger V., Lubke J., Sakmann B. Reliable synaptic connections between pairs of excitatory layer 4 neurones within a single 'barrel' of developing rat somatosensory cortex. J. Physiol. 1999, 521(Pt 1):169-190.
26. Ferreira I.L., Bajouco L.M., Mota S.I., Auberson Y.P., Oliveira C.R., Rego A.C. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 2012, 51:95-106.
27. Foran E., Bogush A., Goffredo M., Roncaglia P., Gustincich S., Pasinelli P., Trotti D. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia 2011, 59:1719-1731.
28. Fuchs A., Rigaud M., Sarantopoulos C.D., Filip P., Hogan Q.H. Contribution of calcium channel subtypes to the intracellular calcium signal in sensory neurons: the effect of injury. Anesthesiology 2007, 107:117-127.
29. Giacomello M., Hudec R., Lopreiato R. Huntington's disease, calcium, and mitochondria. Biofactors 2011, 37:206-218.
30. Grosskreutz J., Van Den Bosch L., Keller B.U. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium 2010, 47:165-174.
31. Gruzman A., Wood W.L., Alpert E., Prasad M.D., Miller R.G., Rothstein J.D., Bowser R., Hamilton R., Wood T.D., Cleveland D.W., Lingappa V.R., Liu J. Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12524-12529.
32. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
33. Guatteo E., Carunchio I., Pieri M., Albo F., Canu N., Mercuri N.B., Zona C. Altered calcium homeostasis in motor neurons following AMPA receptor but not voltage-dependent calcium channels' activation in a genetic model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007, 28:90-100.
34. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
35. Hanson J.E., Smith Y. Subcellular distribution of high-voltage-activated calcium channel subtypes in rat globus pallidus neurons. J. Comp. Neurol. 2002, 442:89-98.
36. Hatton C.J., Shelley C., Brydson M., Beeson D., Colquhoun D. Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant epsilonL221F, inferred from maximum likelihood fits. J. Physiol. 2003, 547:729-760.
37. Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve 2002, 26:438-458.
38. 2+ homeostasis in SOD1G93A mice. Mol. Pharmacol. 2009, 75:478-489.
39. 2+ channels. Mol. Cells 2011, 32:289-294.
40. + current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J. Physiol. 2005, 563:843-854.
41. Lev N., Ickowicz D., Barhum Y., Melamed E., Offen D. DJ-1 changes in G93A-SOD1 transgenic mice: implications for oxidative stress in ALS. J. Mol. Neurosci. 2009, 38:94-102.
42. Liu Q., Wong-Riley M. Developmental changes in the expression of GABAA receptor subunits alpha1, alpha2, and alpha3 in the rat pre-Botzinger complex. J. Appl. Physiol. 2004, 96:1825-1831.
43. Lorenzon N.M., Foehring R.C. Characterization of pharmacologically identified voltage-gated calcium channel currents in acutely isolated rat neocortical neurons. I. Adult neurons. J. Neurophysiol. 1995, 73:1430-1442.
44. Luebke J.I., Dunlap K., Turner T.J. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron 1993, 11:895-902.
45. Mills K.R., Nithi K.A. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 1997, 20:1137-1141.
46. Mintz I.M., Sabatini B.L., Regehr W.G. Calcium control of transmitter release at a cerebellar synapse. Neuron 1995, 15:675-688.
47. Moldovan M., Alvarez S., Pinchenko V., Marklund S., Graffmo K.S., Krarup C. Nerve excitability changes related to axonal degeneration in amyotrophic lateral sclerosis: insights from the transgenic SOD1(G127X) mouse model. Exp. Neurol. 2012, 233:408-420.
48. Nardone R., Buffone E., Florio I., Tezzon F. Changes in motor cortex excitability during muscle fatigue in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2005, 76:429-431.
49. Ozdinler P.H., Benn S., Yamamoto T.H., Guzel M., Brown R.H., Macklis J.D. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(3)A transgenic ALS mice. J. Neurosci. 2011, 31:4166-4177.
50. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7:710-723.
51. Pieri M., Albo F., Gaetti C., Spalloni A., Bengtson C.P., Longone P., Cavalcanti S., Zona C. Altered excitability of motor neurons in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 2003, 351:153-156.
52. Pieri M., Gaetti C., Spalloni A., Cavalcanti S., Mercuri N., Bernardi G., Longone P., Zona C. Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu, Zn superoxide dismutase (Gly93→Ala) mutation. Neuroscience 2003, 122:47-58.
53. Pieri M., Carunchio I., Curcio L., Mercuri N.B., Zona C. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp. Neurol. 2009, 215:368-379.
54. Powers R.K., Binder M.D. Input-output functions of mammalian motoneurons. Rev. Physiol. Biochem. Pharmacol. 2001, 143:137-263.
55. 2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron. J. Neurosci. 2001, 21:3721-3728.
56. Quintanilla R.A., Johnson G.V. Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res. Bull. 2009, 80:242-247.
57. Rao S.D., Weiss J.H. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci. 2004, 27:17-23.
58. Sattler R., Tymianski M. Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 2000, 78:3-13.
59. Sheng Z.H., Westenbroek R.E., Catterall W.A. Physical link and functional coupling of presynaptic calcium channels and the synaptic vesicle docking/fusion machinery. J. Bioenerg. Biomembr. 1998, 30:335-345.
60. Spalloni A., Albo F., Ferrari F., Mercuri N., Bernardi G., Zona C., Longone P. Cu/Zn-superoxide dismutase (GLY93→ALA) mutation alters AMPA receptor subunit expression and function and potentiates kainate-mediated toxicity in motor neurons in culture. Neurobiol. Dis. 2004, 15:340-350.
61. 2+ homeostasis. J. Biol. Chem. 2010, 285:631-643.
62. Takahashi T., Momiyama A. Different types of calcium channels mediate central synaptic transmission. Nature 1993, 366:156-158.
63. + currents in human neuropathy and motor neuron disease estimated by latent addition. Clin. Neurophysiol. 2006, 117:2451-2458.
64. Tortarolo M., Grignaschi G., Calvaresi N., Zennaro E., Spaltro G., Colovic M., Fracasso C., Guiso G., Elger B., Schneider H., Seilheimer B., Caccia S., Bendotti C. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J. Neurosci. Res. 2006, 83:134-146.
65. Turner B.J., Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 2008, 85:94-134.
66. Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009, 8:94-109.
67. Tymianski M., Tator C.H. Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosurgery 1996, 38:1176-1195.
68. Van Den Bosch L., Van Damme P., Bogaert E., Robberecht W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2006, 1762:1068-1082.
69. van Zundert B., Peuscher M.H., Hynynen M., Chen A., Neve R.L., Brown R.H., Constantine-Paton M., Bellingham M.C. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J. Neurosci. 2008, 28:10864-10874.
70. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.-M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
71. Vekrellis K., Xilouri M., Emmanouilidou E., Rideout H.J., Stefanis L. Pathological roles of alpha-synuclein in neurological disorders. Lancet Neurol. 2011, 10:1015-1025.
72. Volonte C., Ciotti M.T., Battistini L. Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry 1994, 17:274-276.
73. 2+, mitochondria and selective motoneuron vulnerability: implications for ALS. Trends Neurosci. 2005, 28:494-500.
74. Vucic S., Kiernan M.C. Abnormalities in cortical and peripheral excitability in flail arm variant amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 2007, 78:849-852.
75. Vucic S., Nicholson G.A., Kiernan M.C. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008, 131:1540-1550.
76. Vucic S., Cheah B.C., Yiannikas C., Kiernan M.C. Cortical excitability distinguishes ALS from mimic disorders. Clin. Neurophysiol. 2011, 122:1860-1866.
77. 2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci. 2000, 23:365-371.
78. 2+ channels in supporting hippocampal synaptic transmission. Science 1994, 264:107-111.
79. Wootz H., Enjin A., Wallen-Mackenzie A., Lindholm D., Kullander K. Reduced VGLUT2 expression increases motor neuron viability in Sod1(G93A) mice. Neurobiol. Dis. 2009, 37:58-66.
80. Wroe R., Wai-Ling Butler A., Andersen P.M., Powell J.F., Al-Chalabi A. ALSOD: the Amyotrophic Lateral Sclerosis online database. Amyotroph. Lateral Scler. 2008, 9:249-250.
81. Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., Rizzuto N. Changes in motor cortex inhibition over time in patients with amyotrophic lateral sclerosis. J. Neurol. 2002, 249:1723-1728.
82. Zona C., Pieri M., Carunchio I. Voltage-dependent sodium channels in spinal cord motor neurons display rapid recovery from fast inactivation in a mouse model of amyotrophic lateral sclerosis. J. Neurophysiol. 2006, 96:3314-3322.